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Transdifferentiation of cultured tubular cells induced by hy-
poxia.
Background. Tubulointerstitial fibrosis leads to progressive
kidney disease and, ultimately, may result in end-stage renal
disease (ESRD). Myofibroblasts, which express a-smooth mus-
cle actin (a-SMA) in their cytoplasm, regulate renal fibro-
genesis. Recent studies suggest that certain interstitial myofi-
broblasts derive from renal tubular cells that have undergone
epithelial-mesenchymal transformation (EMT) (transdifferen-
tiation). However, the role(s) of hypoxia, which is involved in
progressive kidney disease, on tubular EMT remains unclear.
Methods Immortalized rat proximal tubular cells (IRPTC)
were cultured in normobaric hypoxia (1% O2) for 3, 6, or 15
days, with match control in normoxic conditions. a-SMA, vi-
mentin, and desmin chosen as markers of EMT were measured
by immunocytochemistry and immunoblots collagen I produc-
tion and cell motility were chosen as functional assays. Various
concentrations of cobaltous chloride (CoCl2) were used as hy-
poxic mimickers. In vivo studies were carried out in a chronic
ischemic kidney model.
Results. Immunohistochemical studies revealed increased
expression of a-SMA. Striking morphologic changes were
detected after 6 days of hypoxia for a-SMA–positive fibroblast-
like cells (SMA + fib) and after 15 days for a-SMA–positive
myofibroblast-like cells (SMA + myo). Immunoblots confirmed
these findings. Collagen I production increased in a time-
dependent manner parallel to a-SMA expression. Cell motility
assays demonstrated that transformed cells had higher migra-
tory capacity than normal tubular cells. Cobaltous salt also in-
duced a-SMA and collagen I synthesis. Chronic ischemic kidney
revealed in vivo tubular EMT at day 7.
Conclusion. Hypoxia can induce tubular EMT. This process
may play an important role in progression of kidney disease.
Tubulointerstitial fibrosis is presently considered a fi-
nal common pathway of progressive kidney disease even-
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tually leading to end-stage renal disease (ESRD) [1–4].
Therefore, understanding the pathogenesis of interstitial
fibrosis is crucial for developing therapeutic interventions
for kidney diseases. However, the mechanism(s) of renal
fibrogenesis are poorly understood.
Tubulointerstitial fibrosis is characterized by the loss
of renal tubules and interstitial capillaries and the accu-
mulation of matrix proteins. One of the most remarkable
pathologic findings of interstitial fibrosis is the presence
of myofibroblasts, which contain alpha-smooth muscle
actin (a-SMA) in cytoplasm [5, 6]. In the normal kid-
ney, interstitial myofibroblasts are rare. In contrast, my-
ofibroblasts appear in markedly increased numbers in the
fibrotic kidney predominantly within the fibrotic area.
Myofibroblasts are morphologically intermediate be-
tween fibroblasts and smooth muscle cells. Like fibrob-
lasts, myofibroblasts synthesize collagens I and III [7,
8], while they retain a-SMA expression. Accumulating
evidence in both experimental animals and humans has
demonstrated correlation both between the presence of
myofibroblasts and deterioration of renal function and
with long-term prognosis [6, 9–13]. The role of myofi-
broblasts in the fibrogenic process was also supported
by studies showing that once myofibroblasts become de-
tectable in the interstitium, collagen deposition accumu-
lates in the areas in which they reside [14, 15].
The precise origin of myofibroblasts is of interest. Pre-
viously, these cells were thought to be derived from
circulating bone marrow fibroblasts [16]. However, re-
cent work utilizing chimeric animals showed that renal
myofibroblasts were derived de novo from kidney cells
[17]. Growing evidence now indicates that myofibroblasts
transdifferentiate from tubular cells [i.e., undergoing ep-
ithelial to mesenchymal transformation (EMT)]. These
then migrate to the interstitium [18]. Apart from tubular
cells, a role for EMT is well established in many other
types of epithelial cells and is associated with fibrogen-
esis and neovascularization [19, 20]. The mechanisms of
renal tubular EMT are currently the focus of extensive
investigations. In vitro data suggest that tubular EMT can
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be induced by profibrotic cytokines such as transforming
growth factor (TGF-b1) [21, 22], fibroblast growth factor
(FGF) [23], and interleukin-1 (IL-1) [24]. However, a role
for hypoxia, which is a critical mediator of kidney disease
progression [25], in EMT remains to be elucidated.
According to their higher metabolic demands, proxi-
mal tubular cells (PTCs) are more susceptible to hypoxic
stimuli [26]. Previous study showed that under hypoxic
conditions proximal tubular cells dedifferentiate [27].
The expression of profibrotic factors such as collagen I,
TGF-b1, and IL-1 also increases [28]. These changes ap-
pear to be mediated via both hypoxia inducible factor
(HIF-1a)-dependent and independent pathways [29].
We hypothesized that chronic hypoxia stimulates
tubular-myofibroblast transdifferentiation, a crucial step
in renal fibrosis. In this present study, we clarified the
effect of chronic hypoxia on phenotypic and functional
changes of tubular cells in vitro. Our in vivo study sup-
ported the role of hypoxia in tubular EMT as well. We also
explored hypoxia-induced pathways that are involved in
tubular EMT.
METHODS
Cell culture and hypoxic protocol
Immortalized rat proximal tubular cells (IRPTCs)
were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) (Nissui Seiyaku, Tokyo, Japan) with 10%
NaHCO3, 2 mmol/L HEPES, pH 7.5, and 5% fetal bovine
serum (FBS) [30]. For immunohistochemical and motil-
ity assays, IRPTC were seeded in 4- or 8-well chamber
slides (Lab Trek II, Nalgen Nunc, Naperville, IL, USA).
For immunoblot analyses, IRPTCs were seeded in 6 cm
culture dishes. After reaching 50% to 70% confluence,
culture dishes were put in a hypoxic (1% O2, 5% CO2,
37◦C) incubator (Astec Co., Fukuoka, Japan) for 3, 6, or
15 days; control dishes were incubated for equivalent
periods under normoxic conditions (21% O2, 5% CO2,
37◦C). In order to preserve stable hypoxic conditions, the
cells in the hypoxic group were periodically examined
(every 3 days). The culture media were also changed ev-
ery 3 days. Changing process was less than 3 minutes for
each. In some experiments, cells were passaged if over-
confluent. The average time for passaging cells was less
than 8 minutes/dish. Each experiment was repeated three
to eight times.
Cobaltous chloride (CoCl2)
Since most hypoxic stimuli are mediated via HIF-1a,
we used CoCl2 to stabilize HIF-1a without hypoxia. Ten,
30, or 60 lmol/L CoCl2 was added to the culture media
for 6-day experiments [31].
Immunohistochemical analyses
At the end of the experiments, cells in 8-chamber
slides were fixed with acetone and methanol 1:1 at −20◦C
for 10 minutes. Direct immunoperoxidase staining was
performed as previously described [32]. In brief, en-
dogenous peroxidase was blocked with 3% H2O2 for
20 minutes. Nonspecific binding was blocked with 5%
nonfat milk in phosphate-buffered saline (PBS) for
5 minutes. Primary antibodies for a-SMA (mouse anti-a-
SMA, clone asm-1) (Boehringer Mannheim, Mannheim,
Germany), 1:1000, monoclonal mouse antivimentin
(V9) (Dako, Glostrup, Denmark), 1:400, monoclonal
mouse antidesmin (D33) (Dako) 1:100, or monoclonal
mouse anti-HIF-1a, 1:100 (Novus Biological, Little-
ton, CO, USA), were applied at room temperature for
60 minutes. The slides were incubated with biotiny-
lated antimouse immunoglobulin (Vector Laboratories,
Burlingame, CA), 1:400, for 30 minutes, followed by
30 minutes incubation with avidin horseradish peroxidase
(Vector Laboratories), 1:2000. Color was developed with
3,3′ diaminobenzidine tetrahydrochloride (DAB), fol-
lowed by counter-staining with methyl green. For staining
HIF-1a, the signal were amplified with tyramide signal
amplification (TSA) (Perkin-Elmer, Boston, MA, USA)
according to the manufacturer’s instruction [33, 34]. The
slides were then examined by light microscopy (Olympus
BX51, Tokyo, Japan), and pictures were taken by Olym-
pus DP12 system.
Quantitative immunohistochemical analysis
In this study, we observed two phenotypically distinct
populations of a-SMA–positive cells. To explore the find-
ings in more detail, we developed a simple classification.
The first group was composed of elongated, spindle-
shaped hypertrophic cells, as compared to control tubular
cells. These cells resemble fibroblasts that contain a-SMA
rather than myofibroblasts. We defined these cells as a-
SMA positive with fibroblast features (a-SMA + fib).
The other group was composed of hypertrophic cells that
were strongly positive for a-SMA with many projeted cy-
toplasmic borders, which is a typical characteristic of my-
ofibroblasts [35]. Thus, we defined this group as a-SMA
positive myofibroblasts (a-SMA + myo).
To compare the amount of a-SMA–positive cells in
each experiment, cells were systematically counted in
nonoverlapping fields, under 400× magnification, from
the upper panel to the lower panel of the slide. The num-
bers of a-SMA + fib, a-SMA + myo, and total a-SMA–
positive cells per 1000 cells were measured for each exper-
iment. This process was conducted in a blinded manner
twice by the same observer within a 3-week-interval. The
mean of these data was used for analysis. The numbers of
cells positive for vimentin or desmin were also counted
by the same methods per 1000 living cells.
Immunoblots analysis
Tubular cells were plated in 6 cm dishes and were
treated with the same protocol as previously described.
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At the end of the experiments, culture media were re-
moved, and monolayer cells were washed twice with ice
cold PBS, and then were detached with trypsin. Detached
cells were collected, spun down at 4◦C, 1500 rpm for
5 minutes and washed twice with cold PBS. Cells were
then incubated for 30 minutes with ice-cold radioim-
munoprecipitation assay (RIPA) buffer [50 mmol/L Tris-
Cl, 150 mmol/L NaCl, 1% Nonidet P-40, 0.5% sodium
deoyl, 0.1% sodium dodecyl sulfate (SDS)] containing
10 mmol/L phenylmethylsulfonylfluoride (PMSF). Cells
were expelled with force through a 23 G needle five times.
The homogenized samples were centrifuged at 14,000
rpm for 15 minutes. The supernatants were collected,
and protein content was determined with a detergent-
compatible Bradford protein assay (BioRad, Hercules,
CA, USA) according to the manufacturer’s protocol [36].
For measurements of collagen I production, IRPTC and
culture media were precipitated in 67% ethanol at 4◦C
overnight [37]. The precipitated proteins were collected
and dissolved in RIPA buffer. The lysates were stored
at −20◦C until analysis. Equal amounts of protein were
mixed with gel loading buffer under reducing conditions
(0.25 mol/L Tris-HCl, 4% SDS, 10% sucrose, 0.004%
bromphenol blue, 10% 2-mercaptoethanol). Samples
were heated at 100◦C for 5 minutes and run in 8 or 12%
SDS polyacrylamide gels, followed by electrotransfer
to polyvinylidine difluoride (PVDF) membrane (Immo-
bilon, Nihon Millipore, Yonezawa, Japan) or Hybond-
ECL membrane (Amersham International, Buckingham,
UK). The transferred membranes were blocked with 5%
nonfat milk in Tris-buffered saline (TBS), 0.01% Tween-
20 for 30 minutes at room temperature. The membranes
were incubated with polyclonal goat antimouse type I col-
lagen antibody (Southern Biotechnology, Burmingham,
AL, USA) at 1:400 for 60 minute at room temperature,
or with anti-SMA antibody overnight at 4◦C. After ex-
tensive wash in TBS, 0.01%Tween, the bound antibod-
ies were detected with alkaline phosphatase-conjugated
secondary antibodies. 5-bromo-4-chloro-3-indolyl phos-
phate/nitro blue tetrazolium tablets (Sigma Fast) (Sigma
Chemical Co., St. Louis, MO, USA) were used as a sub-
strate. In some experiments, the bound antibodies were
detected by the enhanced chemiluminescence system,
ECL (Amersham International).
Apoptosis and cell toxicity assay
Cell toxicity was evaluated by measuring absolute lac-
tate dehydrogenase (LDH) concentrations (Sigma Di-
agnostics, St. Louis, MO, USA) in culture media at each
change (every 3 days) [38]. The floating cells were counted
by Trypan blue exclusion methods [37]. Apoptosis on a
monolayer in each group was detected by in situ DNA
fragmentation TACS blue label kit (Trevigen, Gaithers-
burg, MD, USA) according to the manufacturer’s instruc-
tion as previous described [32].
Cell motility assay
IRPTC (2 × 105) from the hypoxic group, the normoxic
control group, and the CoCl2-treated group were seeded
into 4-chamber slides containing the corresponding cul-
ture media. Twenty-four hours after passage, cells formed
confluent monolayers. Cuts of 850 ± 43.2 micron width
were made with a sterile scalpel. The cells were imme-
diately washed with PBS to remove all the injured cells
and cytokines. PBS was then replaced with new equiva-
lent culture media, and the cells were incubated for 4 and
12 hours to allow migration [39]. This whole process was
performed in less than 5 minutes. After 4 and 12 hours,
cells were fixed with acetone and methanol as described
above. These cells were stained with methyl green alone
or with anti-aSMA and methyl green counterstaining in
other experiments. The width of the scratch was mea-
sured with NIH imaging system, by selecting the three
narrowest parts, at least 50 microns apart; the means of
three narrowest distances were employed to calculate the
motility distance for each experimental group.
Motility distance = 850 − scratch width microns
2
In vivo study: ischemic nephropathy
Six male Sprague-Dawley rats were subjected to in-
duced ischemic nephropathy as previously described by
Troung et al [40]. In brief, rats were general anesthetize
with diethyl ether. After identification of the left renal
artery, a 26 G needle was placed along the renal artery.
Both artery and needle were ligated with silk twice 0.9 cm
apart, and then the needle was removed. Twenty-four–
hour urines were collected before the operation and at
day 7 after the surgery. At day 7, the ischemic kidneys and
contralateral kidneys were removed and overnight fixed
in Methyl Carnoy’s solution, followed by paraffin embed-
ding. The rehydrated tissues were processed to stain pe-
riodic acid-Schiff (PAS) and a-SMA as described above.
Statistical analysis
All numerical data were presented in mean ± SD. One-
way analysis of variance (ANOVA) with post hoc analy-
sis by least significant different (LSD) method (SPSS for
Windows, version 10.0) was employed to determine the
difference among the groups. The significant level was set
at P < 0.05.
RESULTS
Chronic hypoxia-induced phenotypic changes
in PTCs with de novo expression of a-SMA
Light microscopic examination showed that IRPTC
assumed a cuboidal shape under normoxic condi-
tions. These cells formed a cobblestone-like monolayer
typical of tubular cells. Immunohistochemical staining for
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Fig. 1. Immunohistochemical analysis for a-smooth muscle actin (a-
SMA) expression. (A) Normal immortalized rat proximal tubular cells
(IRPTC) were negative for a-SMA staining. Cells were cuboidal in
shape and arranged in a cobble stone monolayer. Inset showing IRPTC
cultured at a low density. (B) After 3 days of hypoxia, some IRPTC
expressed a-SMA (arrowhead), but the changes in cell morphology
were hardly detectable. (C) After 6 days of hypoxia, many IRPTC were
elongated in shape with dense a-SMA expression in a filamentous form
indicating typical a-SMA + fib morphology (pictures were taken at
the border of monolayers in order to show cell morphology). (D) Fif-
teen days of hypoxia induced advanced morphologic changes in some
a-SMA–positive IRPTC. These cells were enlarged and had many bi-
furcates in their cytoplasm with marked expression of a-SMA. These
cells were defined as a-SMA + myo (pictures were taken at the border
of monolayers in order to show cell morphology).
a-SMA, vimentin, and desmin were all negative under
normoxic conditions (Fig. 1A). These characteristics were
stable for all cells cultured under normoxic conditions in
this study.
After 3 days of hypoxia, some tubular cells expressed
a-SMA in their cytoplasm, but morphologic changes were
not detected (Fig. 1B). a-SMA staining was more in-
tense after 6 days of hypoxia, and significant morpho-
logic changes were observed at this time point. Most of
the a-SMA–positive cells were now elongated in shape
and larger than control tubular cells cultured under nor-
moxia, and were designated as a-SMA + fib (Fig. 1C).
For the longest period of hypoxia (15 days), phenotypic
and morphologic changes were more easily observed
(Fig. 1D), with some cells larger than control tubular cells,
demonstrating intense and filamentous expression of a-
SMA with bifurcations in the cell borders, characteris-
tic of myofibroblasts, and were designated as a-SMA +
myo.
An increase in the number of a-SMA–positive
cells appeared to be dependent on incubation time
under hypoxia
Semiquantitative analysis revealed that expression of
a-SMA and phenotypic changes in hypoxia increased in a
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Fig. 2. An increase in the number of a-smooth muscle actin (a-SMA)–
positive cells was dependent on hypoxic time.
time-dependent manner (Fig. 2). The number of a-SMA–
positive cells was significantly increased after incubation
in hypoxia for 6 and 15 days (63.7 ± 18.29 and 92.69 ±
16.17 per 1000 cells, respectively), as compared to 3.33 ±
1.29 per 1000 cells (P < 0.001). The number of a-SMA
+ fib was significantly increased after 6 days of hypoxia
(56 ± 14.36) and after 15 days of hypoxia (73.22 ± 15.63)
as compared to that of the control group (3.06 ± 0.01)
(P < 0.001). a-SMA + myo was significantly increased
after 15 days of hypoxia.
Hypoxia failed to induce expression of vimentin
or desmin in tubular cells
In addition to a-SMA, vimentin and desmin are mes-
enchymal markers of some subtypes of myofibroblasts
(V-type, VD-type myofibroblast) [33]. Hypoxia failed
to induce expression of desmin or vimentin in IRPTC
(Fig. 3A and B). The amount of desmin or vimentin
did not differ between the hypoxic cells and equiv-
alent controls (Fig. 3C), suggesting that hypoxia per
se did not induce expression of vimetin or desmin in
IRPTC.
Immunoblots analysis confirmed an increase
in a-SMA expression
We carried out the immunoblots analysis to confirm
our immunohistochemical results. The expression of a-
SMA in normoxic control was very little, while a-SMA
was increased in a time dependent manner under hypoxic
conditions, which was consistent with the immunohisto-
chemical analysis (Fig. 4).
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Fig. 3. Hypoxia failed to induce desmin (A)
and vimentin (B) expression (representative
pictures were taken from the border zone of 15
days hypoxia experiments). Semiquantitative
scoring showed that the numbers of desmin or
vimentin positive cells were not increased by
hypoxia (C) (pool data of 3, 6, and 15 days;
N = 3 each) (P value = 1 for desmin and 0.4
for vimentin, respectively)
Production of collagen I was increased
in hypoxic conditions
Collagen type I is a major component of extracellu-
lar matrix in fibrotic kidneys. Immunoblots analysis in
the present study demonstrated increased production of
collagen type I by IRPTC in hypoxic conditions. Produc-
tion of collagen type I was observed in a time-dependent
manner (Fig. 5).
CoCl2 increased a-SMA expression and collagen
I synthesis
Immunohistochemical analysis showed that CoCl2
induced expression of a-SMA in IRPTC in a dose-
dependent manner after a 6-day incubation period. Sixty
micromol/liter of CoCl2 was most effective in induction
of a-SMA expression, whereas lower doses (10 lmol/L)
of CoCl2 demonstrated no effect. While CoCl2 induced
a-SMA expression, morphologic changes of the treated
cells were not as dramatic as those incubated in hypoxia.
Most a-SMA–positive cells were smaller than the control
cells, and elongated in shape (Fig.6A).
Our immunobloting analysis confirmed these find-
ings. CoCl2 also increased a-SMA expression in a dose-
dependent manner (Fig. 6B). Cobalt induced synthesis of
collagen type I as well (Fig. 5). These results suggested
regulation of these phenotypic changes via the HIF-1a–
dependent pathway.
HIF-1a was increased by hypoxia or CoCl2
To confirm the role of hypoxia and a chemical mim-
icker, we identified HIF-1a by immunocytochemical
43 kD- -α-SMA
-CBB
Normoxia
3 days hypoxia
6 days hypoxia
15 days hypoxia
Fig. 4. Immunoblots analysis (top) confirmed increased expression lev-
els of a-smooth muscle actin (a-SMA) in a time-dependent manner.
Amount of protein from representative blot (bottom) visualized with
Coomassie Brilliant Blue (CBB).
methods. In normoxic conditions, HIF-1 a could not be
detected. In contrast HIF-1a was markedly up-regulated
in the hypoxic group predominately in the cell nucleus.
Cells treated with CoCl2 also showed an increase in ex-
pression of HIF-1a (Fig. 7).
Hypoxia increased cell migration of IRPTC
Migration is not a prominent feature of epithelial cells,
including tubular cells. In contrast, interstitial mesenchy-
mal cells, especially myofibroblasts, are motile under
physiologic conditions. We tested the motility function
to examine functional changes of IRPTC under hypoxic
conditions. Four hours after placing a scratch on a mono-
layer, cells under hypoxic conditions migrated further
as compared to normoxic controls. The means of migra-
tory distances were 207.48 ± 92.15, 319.68 ± 52.32, and
386.38 ± 25.95 microns for normoxic, 6 days of hypoxia,
and 15 days of hypoxia, respectively. The majority of
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Fig. 5. Immunublot analysis collagen type I production of collagen
type I was increased by hypoxia in a time-dependent manner.
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Fig. 6. Cobaltous salt induced a-smooth muscle actin (a-SMA) expres-
sion. (A) Immunohistochemical study revealed that 6 days of cobaltous
chloride (CoCl2) (30 and 60 lmol/L)–treated tubular cells expressed
a-SMA. Arrow indicted the a-SMA–positive cells. (B) Imunoblotting
analysis confirmed the increased amount of a-SMA in immortalized rat
proximal tubular cells (IRPTCs) treated with CoCl2.
A B C
Fig. 7. Immunocytochemical analysis of hypoxia inducible factor-1a
(HIF-1a). (A) Normoxic control did not express HIF-1a in nucleus
or cytoplasm. (B) Hypoxic immortalized rat proximal tubular cells
(IRPTCs) strongly expressed HIF-1a in a nucleus-pattern. (C) Six days
of cobaltous chloride (CoCl2) treatment of IRPTC also induced HIF-1a
expression in their nucleuses.
the mobile cells that migrated to the edge of the migra-
tion contained a-SMA in their cytoplasm (Fig. 8). For
12 hours study, the distance between the scratched cells
was even less but significant in the normoxic group, while
the scratches were completely covered with migrating
cells and disappeared in both hypoxic groups (data not
shown).
6 days control
6 days hypoxia
15 days hypoxia
CoCl2
P < 0.05
P < 0.01
0
E
100 200
Distance, microns
300 400 500
Fig. 8. Motility assays. Pictures were taken at 4 hours after a scratch on
confluent monolayer were made. (A) Normoxic control. (B) Six days
of hypoxia. Motility distance was increased. Inset shows most of the
cells moved to the farthest contained a-smooth muscle actin (a-SMA)
in the cytoplasm. (C) Fifteen days of hypoxia demonstrated that the
scratch was almost covered by migrating a-SMA positive tubular cells
(PTCs). (D) Treatment with 60 lmol/L cobaltous chloride (CoCl2) did
not enhance migration of tubular cells. (E) Graph comparing motility
distance between each group. Both hypoxic groups showed significantly
increased motility capacity.
Hypoxia of our condition did not increase apoptosis or
significant cell cytotoxicity
Supernatant LDH concentrations and Trypan blue ex-
clusion assays in each media change did not differ be-
tween hypoxic and match normorxic control (data not
shown). The excretory amount of LDH per total LDH
in the normoxic control was 21.41% ± 0.79% while that
of hypoxic were 22.36% ± 1.97%, 21.16% ± 0.82%, and
23.17% ± 1.65% for 3,6, and 15 day hypoxia, respectively
(Fig. 9G). However, the excretory amount of LDH was
increase to 25.42% + 0.71% in 6 days of 60 lmol/L cobalt
group. In situ DNA fragment labeling assay showed that
apoptosis did not increase. The number of apoptosis cells
in control was 35.5 ± 6.1 per thousand cells. In hypoxic
groups, the number of apoptosis cells was 23.4 ± 2 per
thousand cells for 3-day hypoxia and 43.3 ± 5.6, 41.1 ± 5.5
per thousand cells for 6- and 15-day hypoxia, respectively
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G Fig. 9. In situ DNA fragmentation labelingof immortalized rat proximal tubular cells
(IRPTC). Confluent normoxic control (pic-
ture was taken from 3-day control). (A) Three,
6, and 15 days of hypoxia showing the num-
ber of apoptosis cells did not significantly in-
crease (B to D). However, 6 days of cobal-
tous chloride (CoCl2) 60 lmol/L slightly in-
creased apoptosis (E). Graph comparing the
number of apoptosis cells in each experiment
only 6-day of 60 lmol/L CoCl2 significantly
increase apoptosis; however, the majority of
cells remained survive (F). Graph showing
the amount of culture media lactate dehydro-
genase (LDH)/total LDH in each group (G).
Amount of LDH did not differ between nor-
moxic control and hypoxia; only with high-
dose cobalt that LDH increases. Wide error
bars in the hypoxic groups might indicate
some toxic effects of hypoxia.
(Fig. 9A–D, F). Cobalt increased cell apoptosis. The num-
ber of apoptosis cells in 6 day of 60 lmol/L cobalt increase
to 102.2 ± 20.8 per thousand cells (P < 0.05 ANOVA).
At any rate, the majority of cells remained survived
(Fig. 9E and F). This data suggested the toxicity of chem-
ical hypoxic mimicker and might explain the discrepancy
of our finding between cobalt and hypoxic stimuli.
In vivo transdifferentiation of tubular cells was induced
by chronic ischemia of the kidney
To support the role of hypoxia in transdifferrentia-
tion, we induced chronic ischemic nephropathy in rats.
Our data showed that severe tubulointerstitial damage
rapidly developed as early as 1 week after induce ischemia
(Fig. 10). At this time point, the amount of urinary protein
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Fig. 10. In vivo studies of a chronic ischemic nephropathy model. After
7 days, the chronic ischemic kidneys developed severe tubulointersti-
tial damage and fibrosis, whereas the contralateral kidneys remained
normal, as shown by periodic acid-Schiff (PAS) staining of chronic is-
chemic kidneys (A) and contralateral controls (B). Immunohistochemi-
cal analysis for a-smooth muscle actin (a-SMA) showed many a-SMA–
positive interstitial cells, while tubular cells and interstitial cells in con-
tralateral kidneys did not express a-SMA (C). (D) High magnification
view showed that some tubules in chronic ischemic kidneys strongly
expressed a-SMA (compare to the neighboring arteriole indicated by
an arrow) (E). (F) Graph showing the amount of 24-hour urine protein
excretion did not increase.
excretion did not increase. Immunohistochemical stud-
ies of a-SMA demonstrated a markedly increase of my-
ofibroblasts in the interstitial area. Some tubular cells
strongly expressed SMA, indicating in vivo transdiffer-
entiation. In contrast, the contralateral kidneys remained
normal.
DISCUSSION
Accumulating evidence suggests that chronic hypoxia
is involved in progressive kidney disease. Recent works
have emphasized that the loss of peritubular capillary be-
gins during the early period of renal disease, preceding
the development of tubulointerstitial fibrosis and aggra-
vating tubulointerstitial hypoxia. We previously showed
that peritubular capillary loss occurred in a throm-
botic microangiopathy model [41, 42] while others re-
ported similar findings in remnant kidneys [43], unilateral
ureteral obstruction (UUO) [44], and an anti-glomerular
basement membrane (GBM) nephritis model [45]. In the
present study, we demonstrated the transdifferentiation
of tubular cells by hypoxia, as indicated by de novo ex-
pression of a mesenchymal marker, morphologic changes,
and acquisition of mobility. Furthermore, we demon-
strated in vivo EMT in a chronic ischemic model of the
kidney. Taken together, our results supported the role of
hypoxia in EMT, which is a crucial process in renal fi-
brogenesis [46]. We also propose that the mechanism of
hypoxia-induced EMT may be, at least in part, regulated
by the HIF-1a–dependent pathway.
Hypoxia has many effects on higher eukaryotic cells.
Transcription of many genes is regulated by hypoxic stim-
uli via hypoxia-inducible factors, including vascular en-
dothelial growth factor (VEGF), erythropoietin (EPO),
glucose transporter (GLUT) and heme oxygenase-1
(HO-1) [47]. A variety of profibrotic cytokines are also
up-regulated by hypoxia [37, 48, 49]. For long-term adap-
tation to hypoxia, cells reduce protein synthesis, turn off
unnecessary membrane channels, and decrease cellular
activities [27, 50]. Our work suggests unusual responses
of tubular cells by changing their phenotypes. The num-
ber of a-SMA–positive cells began to increase after 3 days
and reached a plateau in two weeks of hypoxia. The im-
munoblots data also supported these results. Morpho-
logic changes appeared somewhat later. After 6 days of
hypoxia, we observed characteristic myofibroblast-like
morphology in a-SMA–positive cells. It is likely that ex-
pression of a-SMA and EMT may involve many genes
and various steps of cell adaptation. The time course of
EMT in our study is consistent with previous reports
[21]. Yang and Liu [51] and Yang et al [52] previously
showed that EMT needs many steps before completion
of transdifferentiation. However, in this present study,
hypoxia per se could not induce the expression of vi-
mentin and desmin in our tubular cell line. These two anti-
gens are expressed in some, but not all, myofibroblasts.
Studies in liver and lung fibrosis showed that a-SMA–
positive vimentin-negative myofibroblasts participate in
the pathogenesis of this process [8, 53].
In addition to expression of new mesenchymal anti-
gens, loss of normal cytoskeletal and cell-to-cell adhesion
molecules is considered as a part of the EMT process [18,
21–23]. In the present study, we avoided testing the loss of
these antigens because loss of normal structures by nox-
ious stimuli such as hypoxia does not provide conclusive
evidence of transformation. In contrast, hypoxic tubular
cells gained motility function, generally not a feature of
epithelial cells. Increased cell motility has been reported
as one of the features of EMT [54, 55]. Since motility is
an active and energy-consuming process, it is surprising
that hypoxic cells treated for the longest period, which
should lead to the most severe energy depletion, showed
the highest motility. Furthermore, in our motility study,
we found that most of the leading edge cells contained a-
SMA in their cytoplasm. We also measured the amount
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Table 1. Summary of epithelial-mesenchymal transformation (EMT)
data
Hypoxia
Control 3 days 6 days 15 days CoCl2
Morphology Cuboidal Cuboidal Elongated Elongated, Elongated
of cell bifurcated
Size of NC NC Larger Larger Smaller
transformed
cell
a-SMA − + +++ ++++ +++
Desmin − − − − −
Vimentin − − − − −
Collagen I + NA ++++ ++++ ++++
Migration + NA ++++ +++++ +
Abbreviations are: CoCl2, coblaltous chloride; a-SMA, a-smooth muscle actin;
NA, not available; NC, no change.
of collagen I, a major component of the extracellular ma-
trix, which accumulates in fibrotic tissues. Opharnides,
Fine, and Norman [28] demonstrated increased collagen
I synthesis by PTCs in hypoxic conditions. We confirmed
and extended their findings, clarifying that amount of col-
lagen I increased in a time-dependent manner and was
strongly paralleled to EMT. We speculate that the trans-
formed cells may take part in fibrogenesis via collagen I
synthesis.
Cobaltous salt is well established as a chemical mim-
icker of hypoxia by stabilizing HIF1a [33, 37, 47]. In our
study, a-SMA expression and collagen synthesis were
induced by CoCl2 in a dose-dependent manner. Im-
munohistochemical analysis of HIF-1a confirmed up-
regulation of HIF-1a in both hypoxic- and cobalt-treated
groups. These results suggest that HIF-1a may also be in-
volved in tubular EMT-induced by hypoxia. However,
LDH assay and apoptosis study suggested that cobalt
had additional cytotoxicity compared to hypoxia; there-
fore, not all aspects of EMT could be induced by cobalt
(Table 1)
In addition to the results of these in vitro studies, phe-
notypic changes of renal tubular cells were observed
in many experimental models as well as in human dis-
eases [18, 56–58]. It is possible that disruption of the
tubular basement membrane, proteinuria, or infiltrative
macrophages may play a role in in vivo transdifferentia-
tion of tubular cells, the loss of peritubular capillaries and
subsequent hypoxia in tubulointerstitial compartment in
remnant kidneys may also be important [59]. Our in vivo
experiments in chronic ischemic kidneys provided sug-
gestive evidences that chronic ischemia/hypoxia might
induce tubulointersitial fibrosis, as previously described
[40] and tubular EMT. Since we did not observe signifi-
cant proteinuria, this result strongly supported a role of
hypoxia in EMT and progression of renal fibrosis.
CONCLUSION
Our work demonstrates an important role of hypoxia
in tubular EMT, a crucial step in renal fibrosis and pro-
gression of kidney disease. This insight may lead to novel
therapeutic interventions of chronic renal disease in the
future.
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